A global food manufacturer facing repeated FDA import refusals partnered with Freyr to address critical gaps in raw material documentation, formulation alignment, and labeling compliance. The client struggled with missing test parameters, mislabeling, and supplier coordination challenges—impacting product approvals and market continuity.
Freyr deployed a structured compliance framework, including FDA (21 CFR) mapping, import risk assessments, and supplier engagement. By validating labels and closing documentation gaps, Freyr enabled the client to reduce import risks, streamline approvals, and strengthen supply chain transparency.
Download the case study to see how Freyr helped the client achieve FDA-aligned compliance and uninterrupted market access.